Uxin Limited Sponsored ADR UXIN
1.31
0.01
0.77%
as of 25 Sep
- Market cap
- $272.1M
- P/E
- 0.0×
Follow UXIN
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
| P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
| P/S ratio | 2.59 | 2.08 | 1.52 | 1.24 | |
| P/FCF ratio | 0.00 | 0.00 | 0.00 | 0.00 | |
| P/Operating CF | (34.23) | (33.97) | (9.77) | (9.43) | |
| P/B ratio | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price to Tangible BV | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Sales | 3.25 | 2.58 | 1.96 | 1.60 | |
| EV/EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Operating CF | (4.09) | (4.03) | (5.43) | (5.27) | |
| EV/FCF | (3.92) | (3.86) | (5.11) | (4.96) | |
| Quick Ratio | 0.13 | 0.12 | 0.11 | 0.10 | |
| Current Ratio | 0.69 | 0.72 | 0.76 | 0.79 | |
| Net Debt/EBITDA | (31.19) | (34.90) | (22.79) | (20.66) | |
| Debt/Assets | 69.19% | 59.98% | 61.54% | 63.88% | |
| Debt/Equity | (4.96) | (6.58) | (6.45) | (4.47) | |
| Asset Turnover | 2.02 | 1.25 | 1.50 | 1.84 | |
| Operating CF/Net income | 2.11 | 0.00 | 5.46 | 0.00 | |
| Capex/Depreciation | (0.27) | — | (0.34) | — | |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | |
| Research and Development Expense of Revenue | 0.47% | 0.35% | 0.29% | 0.27% | |
| Selling, General and Administrative Expense of Revenue | 14.23% | 13.69% | 12.21% | 12.96% | |
| Intangible Assets out of Total Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Based Compensation of Revenue | 3.00% | 0.00% | 3.57% | 0.00% | |
| Graham Net Nets | (0.35) | (0.35) | (0.39) | (0.42) | |
| Graham Number | 0.88 | 0.74 | 0.82 | 0.99 | |
| Earnings Yield | (5.08%) | (5.20%) | (5.64%) | (6.84%) | |
| Free Cash Flow Yield | (31.94%) | (32.19%) | (25.15%) | (26.07%) | |
| Revenue per Share | 0.44 | 0.58 | 0.85 | 0.70 | |
| Operating CF per Share | (0.10) | 0.00 | (0.34) | 0.00 | |
| Capex per Share | (0.01) | 0.00 | (0.01) | 0.00 | |
| Free Cash Flow per Share | (0.11) | 0.00 | (0.36) | 0.00 | |
| Cash per Share | 0.05 | 0.05 | 0.06 | 0.03 | |
| Shareholders Equity per Share | (0.19) | (0.13) | (0.16) | (0.21) | |
| Interest Debt per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book value per Share | (0.19) | (0.13) | (0.16) | (0.21) | |
| Free Cash Flow | (22.89) | — | (75.14) | — | |
| Working Capital | (28.23) | (32.26) | (33.32) | (22.63) | |
| Capital Expenditures | (1.11) | — | (3.02) | — | |
| Net Current Asset Value | (262.63) | (260.57) | (272.52) | (283.85) | |
| EV/EBIT | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capex to Sales | 0.01 | 0.00 | 0.02 | 0.00 | |
| Net Profit Margin | (11.21%) | (7.18%) | (7.40%) | (9.13%) | |
| Price to Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
| Average Receivables | 2.56 | 3.37 | 3.45 | 3.09 | |
| Average Payables | 10.86 | 10.00 | 10.54 | 10.16 | |
| Average Inventory | 27.16 | 38.36 | 52.03 | 43.68 | |
| Average Assets | 142.64 | 283.86 | 308.62 | 299.15 | |
| Average Common Equity | (40.20) | (35.41) | (40.31) | (44.54) |
Columns are period end dates